Imagine a mid-sized academic lab that just secured grant funding. The principal investigator needs GLP-1 agonists for one study, healing peptides for another, and a few mitochondrial compounds for an exploratory project – all within the same fiscal quarter, and all documented well enough to survive a procurement audit. Three vendors later, they’re stuck with […]

0